Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0584
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era ; volume:95 ; number:12 ; day:26 ; month:9 ; year:2016 ; pages:2017-2022 ; date:12.2016
Annals of hematology ; 95, Heft 12 (26.9.2016), 2017-2022, 12.2016
- Urheber
-
Yuda, Sayako
- Beteiligte Personen und Organisationen
-
Maruyama, Dai
Maeshima, Akiko Miyagi
Makita, Shinichi
Kitahara, Hideaki
Miyamoto, Ken-ichi
Fukuhara, Suguru
Munakata, Wataru
Suzuki, Tatsuya
Kobayashi, Yukio
Tajima, Kinuko
Taniguchi, Hirokazu
Tobinai, Kensei
SpringerLink (Online service)
- DOI
-
10.1007/s00277-016-2800-1
- URN
-
urn:nbn:de:1111-2016112710670
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yuda, Sayako
- Maruyama, Dai
- Maeshima, Akiko Miyagi
- Makita, Shinichi
- Kitahara, Hideaki
- Miyamoto, Ken-ichi
- Fukuhara, Suguru
- Munakata, Wataru
- Suzuki, Tatsuya
- Kobayashi, Yukio
- Tajima, Kinuko
- Taniguchi, Hirokazu
- Tobinai, Kensei
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-term outcomes of patients with primary intestinal follicular lymphoma managed with watch-and-wait strategy
Has the time to come leave the “watch-and-wait” strategy in newly diagnosed asymptomatic follicular lymphoma patients?
Follicular lymphoma
Watch and Wait, Worth It?
Rituximab response in follicular lymphoma: contributions from KIR 2DS1 and HLA-C
Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma
A rare face of follicular lymphoma: reverse variant of follicular lymphoma
Atypical burkitt's lymphoma transforming from follicular lymphoma
Follicular lymphoma of the duodenum
Follicular lymphoma of the duodenum
Follicular lymphoma and marginal zone lymphoma: how many diseases?
Constitutive AKT activation in follicular lymphoma
Long-term outcomes of patients with primary intestinal follicular lymphoma managed with watch-and-wait strategy
Has the time to come leave the “watch-and-wait” strategy in newly diagnosed asymptomatic follicular lymphoma patients?
Follicular lymphoma
Watch and Wait, Worth It?
Rituximab response in follicular lymphoma: contributions from KIR 2DS1 and HLA-C
Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma
A rare face of follicular lymphoma: reverse variant of follicular lymphoma
Atypical burkitt's lymphoma transforming from follicular lymphoma
Follicular lymphoma of the duodenum
Follicular lymphoma of the duodenum
Follicular lymphoma and marginal zone lymphoma: how many diseases?
Constitutive AKT activation in follicular lymphoma
Long-term outcomes of patients with primary intestinal follicular lymphoma managed with watch-and-wait strategy
Has the time to come leave the “watch-and-wait” strategy in newly diagnosed asymptomatic follicular lymphoma patients?
Follicular lymphoma
Watch and Wait, Worth It?
Rituximab response in follicular lymphoma: contributions from KIR 2DS1 and HLA-C
Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma
A rare face of follicular lymphoma: reverse variant of follicular lymphoma
Atypical burkitt's lymphoma transforming from follicular lymphoma
Follicular lymphoma of the duodenum
Follicular lymphoma of the duodenum
Follicular lymphoma and marginal zone lymphoma: how many diseases?